Your browser doesn't support javascript.
loading
Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis.
Mo, Xiao-Dong; Hong, Shen-Da; Zhao, Yan-Li; Jiang, Er-Lie; Chen, Jing; Xu, Yang; Sun, Zi-Min; Zhang, Wei-Jie; Liu, Qi-Fa; Liu, Dai-Hong; Wan, Ding-Ming; Mo, Wen-Jian; Ren, Han-Yun; Yang, Ting; Huang, He; Zhang, Xi; Wang, Xiao-Ning; Song, Xian-Min; Gao, Su-Jun; Wang, Xin; Chen, Yi; Xu, Bing; Jiang, Ming; Huang, Xiao-Bing; Li, Xin; Zhang, Hong-Yu; Wang, Hong-Tao; Wang, Zhao; Niu, Ting; Wang, Ji-Shi; Xia, Ling-Hui; Liu, Xiao-Dan; Li, Fei; Zhou, Fang; Lang, Tao; Hu, Jiong; Wu, Sui-Jing; Huang, Xiao-Jun.
Afiliación
  • Mo XD; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Hong SD; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences (2019RU029), Beijing, China.
  • Zhao YL; National Institute of Health Data Science at Peking University, Peking University Health Science Center, Beijing, China.
  • Jiang EL; Hebei Yanda Lu Daopei Hospital, Beijing Lu Daopei Institute of Hematology, Beijing, China.
  • Chen J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Xu Y; Department of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Sun ZM; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhang WJ; Department of Hematology, the First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Liu QF; Department of Hematology, Aerospace Center Hospital, Beijing, China.
  • Liu DH; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wan DM; Department of Hematology, Chinese PLA General Hospital, Beijing, China.
  • Mo WJ; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Ren HY; Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Yang T; Department of Hematology, Peking University First Hospital, Beijing, China.
  • Huang H; Fujian Medical University Union Hospital, Fujian Institute of Hematology, Department of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou, China.
  • Zhang X; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wang XN; Medical Center of Hematology, Xinqiao Hospital, Army Medical University; State Key Laboratory of Trauma, Burn and Combined Injury, Chongqing, China.
  • Song XM; Department of Hematology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Gao SJ; Department of Hematology, Shanghai general Hospital affiliated to Shanghai Jiaotong University, Shanghai, China.
  • Wang X; Department of Hematology, the First Hospital of Jilin University, Changchun, China.
  • Chen Y; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Xu B; Department of Hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou Key Laboratory of Hematology, Wenzhou, China.
  • Jiang M; The First Affiliated Hospital of Xiamen University, Xiamen University Institute of Hematology, Xiamen, China.
  • Huang XB; Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region Research Institute of Hematology Xinjiang Medical University, Urumqi, China.
  • Li X; Department of Hematology, Sichuan Provincial People's Hospital, Affiliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
  • Zhang HY; Department of Hematology, the Third Xiangya Hospital, Central South University, Changsha, China.
  • Wang HT; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Wang Z; Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Niu T; Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Wang JS; Department of Hematology, West China hospital, Sichuan University, Chengdu, China.
  • Xia LH; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Department of Hematology, Key Laboratory of Hematological Disease Diagnostic and Treat Centre of Guizhou Province, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Liu XD; Division of Bone Marrow Transplantation, Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li F; Department of Hematology, the Affiliated Hospital of Qingdao University, Qingdao, China.
  • Zhou F; Department of Hematology, the First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Lang T; Department of Hematology, the 960 Hospital of the PLA Joint Logistics Support Force, Jinan, China.
  • Hu J; Department of Hematology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
  • Wu SJ; Blood and Marrow Transplantation Center, Department of Hematology, Shanghai Institute of Hematology, Collaborative Innovation Center of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Huang XJ; Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
Am J Hematol ; 97(4): 458-469, 2022 04.
Article en En | MEDLINE | ID: mdl-35064928
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: China